Gene: PDGFA
Official Full Name: platelet derived growth factor subunit Aprovided by HGNC
Gene Summary: This gene encodes a member of the protein family comprised of both platelet-derived growth factors (PDGF) and vascular endothelial growth factors (VEGF). The encoded preproprotein is proteolytically processed to generate platelet-derived growth factor subunit A, which can homodimerize, or alternatively, heterodimerize with the related platelet-derived growth factor subunit B. These proteins bind and activate PDGF receptor tyrosine kinases, which play a role in a wide range of developmental processes. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO09072 | PDGFA Knockout cell line (HeLa) | Human | PDGFA | 1:3~1:6 | Negative | Online Inquiry |
KO09073 | PDGFA Knockout cell line (HCT 116) | Human | PDGFA | 1:2~1:4 | Negative | Online Inquiry |
KO09074 | PDGFA Knockout cell line (HEK293) | Human | PDGFA | 1:3~1:6 | Negative | Online Inquiry |
KO09075 | PDGFA Knockout cell line (A549) | Human | PDGFA | 1:3~1:4 | Negative | Online Inquiry |
PDGFA Gene Knockout Cell Lines are specialized cellular models designed for the study of platelet-derived growth factor A (PDGFA) signaling pathways and their biological implications. These cells are generated through targeted gene editing techniques, such as CRISPR/Cas9, enabling researchers to elucidate the roles of PDGFA in various physiological and pathological processes. By knocking out the PDGFA gene, these cell lines provide a powerful tool for dissecting the intricate signaling pathways that modulate cell proliferation, differentiation, and migration, critical aspects in development, wound healing, and cancer metastasis.
The primary function of PDGFA is to bind to its cognate receptors, PDGFR-α and PDGFR-β, initiating a cascade of downstream signaling events that influence cellular behavior. Through the use of these knockout cell lines, scientists can directly observe the impact of PDGFA absence on cellular functions, enabling them to clarify the gene's role in tumorigenesis and other diseases characterized by dysregulated cell growth. This model is particularly valuable in drug discovery and therapeutic development, providing insights into potential targets for intervention.
One of the unique advantages of PDGFA Gene Knockout Cell Lines lies in their specificity and reproducibility, allowing for the establishment of robust experimental conditions that are often lacking in traditional models. Unlike alternative approaches that might only inhibit PDGFA function pharmacologically, these knockout lines offer a complete abrogation of the gene's expression, facilitating clearer and more controlled experiments.
For researchers and clinicians focused on cancer biology, regenerative medicine, or vascular development, these knockout cell lines present a significant opportunity to advance understanding of PDGFA-related mechanisms and develop novel therapeutic strategies. Utilizing the expertise of our company in gene editing and cellular model creation, we deliver high-quality PDGFA Gene Knockout Cell Lines that support innovative research and foster scientific breakthroughs in the life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.